CBUF:F:F-iShares V Public Limited Company - iShares MSCI World Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.592

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.28 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

-3.70 (-0.61%)

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.12 (-0.21%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.04 (-0.24%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.55 (-0.23%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

-0.65 (-0.60%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-1.10 (-1.01%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.29%)

USD 38.52B
0ZC:F Zscaler Inc

-1.66 (-0.94%)

USD 37.92B

ETFs Containing CBUF:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.12% 25% F 46% F
Dividend Return 1.08% 7% C- 8% B-
Total Return 0.96% 25% F 41% F
Trailing 12 Months  
Capital Gain -0.12% 25% F 46% F
Dividend Return 1.08% 7% C- 8% B-
Total Return 0.96% 25% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.51% 39% F 46% F
Dividend Return 1.65% 37% F 40% F
Total Return 0.15% 18% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 4.47% 92% A 98% N/A
Risk Adjusted Return 36.98% 47% F 58% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.